These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 785988)

  • 21. [Clinical observations on effects of disopyramide on arrhythmias].
    Hu BL; Tao SQ; Liu LS; Chen ZJ; Lu ZL; Wang J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1981 Jun; 3 Suppl 1():60-2. PubMed ID: 6459881
    [No Abstract]   [Full Text] [Related]  

  • 22. Antiarrhythmic and electrocardiographic effects of single oral doses of disopyramide.
    Hulting J; Jansson B
    Eur J Clin Pharmacol; 1977 Jan; 11(2):91-9. PubMed ID: 320015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous and oral disopyramide after myocardial infarction.
    Nicholls DP; Haybyrne T; Barnes PC
    Lancet; 1980 Nov; 2(8201):936-8. PubMed ID: 6107587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of and adverse effects of disopyramide. Comparison of capsules, controlled release tablets and placebo in patients with chronic ventricular arrhythmias.
    Ekelund LG; Nilsson E; Walldius G
    Eur J Clin Pharmacol; 1986; 29(6):673-7. PubMed ID: 3519236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral disopyramide for the prevention of arrhythmias in patients with acute myocardial infarction admitted to open wards.
    Zainal N; Carmichael DJ; Griffiths JW; Besterman EM; Kidner PH; Gillham AD; Summers GD
    Lancet; 1977 Oct; 2(8044):887-9. PubMed ID: 72237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of disopyramide and aprindine on arrhythmias after acute myocardial infarction.
    Pouleur H; Chaudron JM; Reyns P
    Eur J Cardiol; 1977 Jul; 5(5):397-404. PubMed ID: 330168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical studies of Norpace (Part II).
    Vismara L
    Angiology; 1975 Jan; 26(1 Pt 2):132-6. PubMed ID: 1090213
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of low oral doses of disopyramide and amiodarone on ventricular and atrial arrhythmias of chagasic patients with advanced myocardial damage.
    Carrasco HA; Vicuña AV; Molina C; Landaeta A; Reynosa J; Vicuña N; Fuenmayor A; López F
    Int J Cardiol; 1985 Dec; 9(4):425-38. PubMed ID: 3908329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical studies of Norpace (Part VIII).
    Laidlaw JC
    Angiology; 1975 Jan; 26(1 Pt 2):144-5. PubMed ID: 1090215
    [No Abstract]   [Full Text] [Related]  

  • 30. Acute termination of cardiac arrhythmias with intravenous disopyramide.
    Ee BK; Chia BL; Ng RA; Oh V; Tan AT; Choo M
    Singapore Med J; 1982 Aug; 23(4):185-90. PubMed ID: 7178900
    [No Abstract]   [Full Text] [Related]  

  • 31. Cardiac depression by intravenous disopyramide in patients with left ventricular dysfunction.
    Leach AJ; Brown JE; Armstrong PW
    Am J Med; 1980 Jun; 68(6):839-44. PubMed ID: 7386491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemodynamic and electrocardiographic effects of disopyramide in patients with ventricular arrhythmia.
    Hulting J; Rosenhamer G
    Acta Med Scand; 1976; 199(1-2):41-51. PubMed ID: 1251772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the efficacy of propafenone versus disopyramide for complex premature ventricular contractions. Evaluation with long-term monitoring.
    Naccarella F; Palmieri M; del Corso P; Lombardi G; Bracchetti D
    Arzneimittelforschung; 1982; 32(5):547-50. PubMed ID: 7201833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of postligation administration of ORG 6001 and disopyramide on early ischaemia-induced arrhythmias in the anaesthetized rat.
    Marshall RJ; Muir AW; Winslow E
    Br J Pharmacol; 1982 Aug; 76(4):501-3. PubMed ID: 7104520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disopyramide phosphate (Norpace): a new antiarrhythmic drug.
    Yu PN
    Circulation; 1979 Feb; 59(2):236-7. PubMed ID: 758991
    [No Abstract]   [Full Text] [Related]  

  • 36. The hemodynamic effects of Norpace. (Part II).
    Willis PW
    Angiology; 1975 Jan; 26(1 Pt 2):102-10. PubMed ID: 1115396
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical studies of Norpace (Part IV).
    Jutzy RV
    Angiology; 1975 Jan; 26(1 Pt 2):138-9. PubMed ID: 803798
    [No Abstract]   [Full Text] [Related]  

  • 38. [Disopyramide in heart arrhythmias].
    Pellegrino L; Di Michele A; Prencipe D
    Boll Soc Ital Cardiol; 1972; 17(8):617-25. PubMed ID: 4655948
    [No Abstract]   [Full Text] [Related]  

  • 39. Disopyramide--an effective treatment for lignocaine resistant ventricular dysrhythmias.
    Green AG
    Scott Med J; 1979 Jan; 24(1):21-4. PubMed ID: 91197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A placebo-controlled study to determine the efficacy of oral disopyramide phosphate for the prophylaxis of ventricular dysrhythmias after acute myocardial infarction.
    Kumana CR; Rambihar VS; Tanser PH; Cairns JA; Gupta RN; Wildeman RA; Johnston M; Johnson AL; Gent M
    Br J Clin Pharmacol; 1982 Oct; 14(4):519-27. PubMed ID: 6753887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.